Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Emerg Infect Dis ; 25(9): 1745-1747, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31441755

RESUMO

Tucson, Arizona, USA, is a highly coccidioidomycosis-endemic area. We conducted a retrospective review of 815 patients in Tucson over 2.7 years. Of 276 patients with coccidioidomycosis, 246 had a delay in diagnosis; median delay was 23 days. Diagnosis delay was associated with coccidioidomycosis-related costs totaling $589,053 and included extensive antibacterial drug use.


Assuntos
Coccidioidomicose/epidemiologia , Diagnóstico Tardio/economia , Pneumopatias Fúngicas/epidemiologia , Arizona/epidemiologia , Coccidioidomicose/diagnóstico , Coccidioidomicose/economia , Custos e Análise de Custo , Feminino , Humanos , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/economia , Masculino , Prontuários Médicos , Pessoa de Meia-Idade , Estudos Retrospectivos
2.
Am J Respir Crit Care Med ; 200(5): 535-550, 2019 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-31469325

RESUMO

Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature related to diagnosis of invasive pulmonary aspergillosis, invasive candidiasis, and the common endemic mycoses was systematically reviewed. Meta-analysis was performed when appropriate. Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation approach.Results: This guideline includes specific recommendations on the use of galactomannan testing in serum and BAL and for the diagnosis of invasive pulmonary aspergillosis, the role of PCR in the diagnosis of invasive pulmonary aspergillosis, the role of ß-d-glucan assays in the diagnosis of invasive candidiasis, and the application of serology and antigen testing in the diagnosis of the endemic mycoses.Conclusions: Rapid, accurate diagnosis of fungal infections relies on appropriate application of laboratory testing, including antigen testing, serological testing, and PCR-based assays.


Assuntos
Candidíase Invasiva , Cuidados Críticos , Aspergilose Pulmonar Invasiva , Reação em Cadeia da Polimerase , Humanos , Candidíase Invasiva/diagnóstico , Candidíase Invasiva/imunologia , Cuidados Críticos/normas , Galactose/análogos & derivados , Aspergilose Pulmonar Invasiva/diagnóstico , Aspergilose Pulmonar Invasiva/imunologia , Mananas , Reação em Cadeia da Polimerase/métodos , Sorologia/métodos , Sociedades Médicas , Estados Unidos
3.
Ann Am Thorac Soc ; 16(9): 1179-1188, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31219341

RESUMO

Rationale: Prompt diagnosis of invasive fungal infections is important because of the associated morbidity and mortality; however, diagnosis is challenging because of the nonspecific symptoms and radiographic findings.Objectives: To conduct a systematic review and meta-analysis of studies that evaluated the diagnostic accuracy of serum and bronchoalveolar lavage (BAL) galactomannan (GM) and serum or BAL polymerase chain reaction (PCR) in patients with suspected invasive aspergillosis (IA), ß-d-glucan in critically ill patients at risk for candidiasis or candidemia, and serology testing and antigen detection in patients with endemic mycoses (histoplasmosis, blastomycosis, and coccidioidomycosis).Methods: Studies were selected and appraised by pairs of reviewers. Bivariate random effects meta-analysis was used to generate pooled sensitivity, specificity, and diagnostic likelihood ratios.Results: Serum GM in patients with impaired immunity suspected of having IA had sensitivity of 0.71 (95% confidence interval [CI], 0.64-0.78) and specificity of 0.89 (95% CI, 0.84-0.92). A cutoff of 1 optical density index yielded optimal sensitivity and specificity. BAL GM in patients with impaired immunity suspected of having IA had sensitivity of 0.84 (95% CI, 0.73-0.91) and specificity of 0.88 (95% CI, 0.81-0.91). Serum or whole-blood PCR in immunocompromised patients with suspected IA had sensitivity of 0.81 (95% CI, 0.73-0.86) and specificity of 0.79 (95% CI, 0.68-0.86). BAL PCR in patients at high risk for IA had high sensitivity of 0.90 (95% CI, 0.77-0.96) and specificity of 0.96 (95% CI, 0.93-0.98) for diagnosing IA. ß-d-glucan assay in patients in the intensive care unit at risk for invasive candidiasis or candidemia had sensitivity of 0.81 (95% CI, 0.74-0.86) and specificity of 0.60 (95% CI, 0.49-0.71). Data on diagnostic accuracy of antigen detection and serology testing for endemic mycoses were limited and heterogeneous (varied according to test, patient immunity, and suspected endemic disease).Conclusions: The diagnosis of invasive fungal infections remains a challenge. Various serum and BAL markers can aid in diagnosis. This evidence supports the development of clinical practice recommendations by the American Thoracic Society.


Assuntos
Aspergilose/diagnóstico , Líquido da Lavagem Broncoalveolar/microbiologia , Hospedeiro Imunocomprometido , Infecções Fúngicas Invasivas/diagnóstico , Mananas/sangue , Aspergilose/imunologia , Biomarcadores/sangue , Galactose/análogos & derivados , Humanos , Infecções Fúngicas Invasivas/imunologia , Guias de Prática Clínica como Assunto , Sensibilidade e Especificidade
4.
Clin Chest Med ; 38(3): 417-433, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28797486

RESUMO

Coccidioidomycosis is a leading cause of community-acquired pneumonia within its traditional endemic zone in the Southwestern United States and portions of Mexico and Central and South America. Its incidence has increased dramatically within the endemic region; its presence outside of the region, facilitated by a mobile society, is also now substantial. Although only a fraction of the incident disease progresses beyond subclinical illness, this proportion is large in absolute terms and causes substantial disease burden. Diagnosis often depends on serologic interpretation. Treatment has been revolutionized by azole therapy. Controversy remains regarding the decision to treat in less severe disease.


Assuntos
Antifúngicos/uso terapêutico , Coccidioidomicose/diagnóstico , Coccidioidomicose/terapia , Coccidioidomicose/patologia , Humanos
7.
Wilderness Environ Med ; 24(4): 452-3, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24140190
8.
Acad Radiol ; 18(7): 876-84, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21669353

RESUMO

RATIONALE AND OBJECTIVES: With employment of both multidetector computed tomography (MDCT) and endobronchial procedures in multicenter studies, effects of timing of endobronchial procedures on quantitative imaging (Q-MDCT) metrics is a question of increasing importance. MATERIALS AND METHODS: Six subjects were studied via MDCT at baseline, immediately following and at 4 hours and 24 hours post-bronchoalveolar lavage (BAL) (right middle lobe and lingula). Through quantitative image analysis, non-air, or "tissue" volume (TV) in each lung and lobe was recorded. Change in TV from baseline was used to infer retention and redistribution of lavage fluid. RESULTS: Bronchoscopist reported unrecovered BAL volume correlated well with Q-MDCT for whole lung measures, but less well with individual lobes indicating redistribution. TV in all lobes except the right lower lobe differed significantly (P < .05) from baseline immediately post lavage. At 24 hours, all lobes except the left lower lobe (small 1% mean difference at 24 hours) returned to baseline. CONCLUSIONS: These findings suggest fluid movement affecting Q-MDCT metrics between lobes and between lungs before eventual resolution, and preclude protocols involving the lavage of one lung and imaging of the other to avoid interactions. We demonstrate that Q-MDCT is sensitive to lavage fluid retention and redistribution, and endobronchial procedures should not precede Q-MDCT imaging by less than 24 hours.


Assuntos
Lavagem Broncoalveolar , Pulmão/diagnóstico por imagem , Testes de Função Respiratória/métodos , Tomografia Computadorizada por Raios X/métodos , Adulto , Feminino , Humanos , Masculino , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA